文献速递主动脉疾病

重度主动脉瓣狭窄合并肾下腹主动脉瘤的联合经导管治疗

Combined Transcatheter Treatment of Severe Aortic Valve Stenosis and Infrarenal Abdominal Aortic Aneurysm in Increased Surgical Risk Patients.
PubMed 文献 · Ann Vasc Surg · 2019-06-12

本文报道2例重度症状性主动脉瓣狭窄合并肾下腹主动脉瘤患者,成功接受经股动脉经导管主动脉瓣植入(TAVI)联合血管内动脉瘤修复(EVAR)。病例显示经导管技术的多样性,提示在精心选择的患者中,由多学科专家操作,TAVI+EVAR联合手术安全有效。

要点

  • 重度主动脉瓣狭窄合并腹主动脉瘤患者,若未充分处理,均与不良结局相关。
  • 联合TAVI和EVAR在多学科专家操作下,对精心选择的患者安全有效。
  • 目前尚无明确推荐,最佳治疗选择具有挑战性。

核心结论

  • 在精心选择的患者中,由多学科专家操作,TAVI联合EVAR的联合手术安全有效。

研究设计与样本

  • 病例报告,共2例重度症状性主动脉瓣狭窄合并肾下腹主动脉瘤患者。

主要发现

  • 2例患者均成功接受经股动脉TAVI联合EVAR。
  • 联合手术展示了经导管技术的多样性。

临床怎么用

  • 对于合并重度主动脉瓣狭窄和肾下腹主动脉瘤的高手术风险患者,可考虑在多学科团队评估下行TAVI+EVAR联合手术。

局限性

  • 仅基于2例病例报告,证据级别有限,结论需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The prevalence of combined severe aortic stenosis and abdominal aortic aneurysm is increasing with the aging of the population. Both conditions are associated with adverse outcome if not adequately managed. The choice of the optimal treatment of these patients is challenging and no clear recommendations are available. We report 2 cases of patients with concomitant severe symptomatic aortic stenosis and infrarenal abdominal aortic aneurysm successfully treated with combined transfemoral transcatheter aortic valve implantation (TAVI) and endovascular aortic aneurysm repair (EVAR). The reported cases demonstrate the versatility of transcatheter techniques and suggest that, in carefully selected patients, the combined procedure of TAVI plus EVAR, if performed by multidisciplinary expert operators, is safe and effective.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mauri S, Bozzani A, Ferlini M, et al. Combined Transcatheter Treatment of Severe Aortic Valve Stenosis and Infrarenal Abdominal Aortic Aneurysm in Increased Surgical Risk Patients. Ann Vasc Surg. 2019. PMID: 31200060. doi:10.1016/j.avsg.2019.03.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。